Lawrence H. Young
Affiliations: | Yale University, New Haven, CT |
Area:
Physiology Biology, Biomedical EngineeringGoogle:
"Lawrence Young"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Inzucchi SE, Viscoli CM, Young LH, et al. (2019) Diabetes prevention and cardiovascular complications. Diabetologia |
| Ma Y, Su KN, Pfau D, et al. (2019) Cardiomyocyte d-dopachrome tautomerase protects against heart failure. Jci Insight. 4 |
| Pfau D, Thorn SL, Zhang J, et al. (2019) Angiotensin Receptor Neprilysin Inhibitor Attenuates Myocardial Remodeling and Improves Infarct Perfusion in Experimental Heart Failure. Scientific Reports. 9: 5791 |
| Spence JD, Viscoli CM, Inzucchi SE, et al. (2019) Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial. Jama Neurology |
| Viscoli CM, Kent DM, Conwit R, et al. (2018) Scoring System to Optimize Pioglitazone Therapy After Stroke Based on Fracture Risk. Stroke. STROKEAHA118022745 |
| Dearborn JL, Viscoli CM, Inzucchi SE, et al. (2018) Metabolic syndrome identifies normal weight insulin-resistant stroke patients at risk for recurrent vascular disease. International Journal of Stroke : Official Journal of the International Stroke Society. 1747493018816425 |
| Wang D, Hu X, Lee SH, et al. (2018) Diabetes Exacerbates Myocardial Ischemia/Reperfusion Injury by Down-Regulation of MicroRNA and Up-Regulation of O-GlcNAcylation. Jacc. Basic to Translational Science. 3: 350-362 |
| Young LH, Viscoli CM, Schwartz GG, et al. (2018) Heart Failure After Ischemic Stroke or TIA in Insulin-Resistant Patients Without Diabetes Treated with Pioglitazone. Circulation |
| INZUCCHI SE, VISCOLI CM, YOUNG LH, et al. (2018) What Mediated Pioglitazone's Cardiovascular (CV) Benefit in the IRIS Trial? Diabetes. 67: 17-LB |
| Yaghi S, Furie K, Viscoli CM, et al. (2018) Abstract 101: Pioglitazone Prevents Stroke in Patients With a Recent TIA or Ischemic Stroke: a Secondary Analysis of the IRIS Trial Stroke. 49 |